Literature DB >> 15153793

Flavonoids such as luteolin, fisetin and apigenin are inhibitors of interleukin-4 and interleukin-13 production by activated human basophils.

Toru Hirano1, Shinji Higa, Junsuke Arimitsu, Tetsuji Naka, Yoshihito Shima, Shiro Ohshima, Minoru Fujimoto, Tomoki Yamadori, Ichiro Kawase, Toshio Tanaka.   

Abstract

BACKGROUND: We have previously shown that fisetin, a flavonol, inhibits IL-4 and IL-13 synthesis by allergen- or anti-IgE-antibody-stimulated basophils. This time, we investigated the inhibition of IL-4 and IL-13 production by basophils by other flavonoids and attempted to determine the fundamental structure of flavonoids related to inhibition. We additionally investigated whether flavonoids suppress leukotriene C4 synthesis by basophils and IL-4 synthesis by T cells in response to anti-CD3 antibody.
METHODS: Highly purified peripheral basophils were stimulated for 12 h with anti-IgE antibody alone or anti-IgE antibody plus IL-3 in the presence of various concentrations of 18 different kinds of flavones and flavonols. IL-4 and IL-13 concentrations in the supernatants were then measured. Leukotriene C4 synthesis was also measured after basophils were stimulated for 1 h in the presence of flavonoids. Regarding the inhibitory activity of flavonoids on IL-4 synthesis by T cells, peripheral blood mononuclear cells were cultured with flavonoids in anti-CD3-antibody-bound plates for 2 days.
RESULTS: Luteolin, fisetin and apigenin were found to be the strongest inhibitors of both IL-4 and IL-13 production by basophils but did not affect leukotriene C4 synthesis. At higher concentrations, these flavonoids suppressed IL-4 production by T cells. Based on a hierarchy of inhibitory activity, the basic structure for IL-4 inhibition by basophils was determined.
CONCLUSIONS: Due to the inhibitory activity of flavonoids on IL-4 and IL-13 synthesis, it can be expected that the intake of flavonoids, depending on the quantity and quality, may ameliorate allergic symptoms or prevent the onset of allergic diseases. Copyright 2004 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15153793     DOI: 10.1159/000078498

Source DB:  PubMed          Journal:  Int Arch Allergy Immunol        ISSN: 1018-2438            Impact factor:   2.749


  24 in total

1.  A novel retinoic acid, catechin hydrate and mustard oil-based emulsion for enhanced cytokine and antibody responses against multiple strains of HIV-1 following mucosal and systemic vaccinations.

Authors:  Mingke Yu; Michael Vajdy
Journal:  Vaccine       Date:  2011-01-25       Impact factor: 3.641

Review 2.  Current status and challenges of cytokine pharmacology.

Authors:  Z Zídek; P Anzenbacher; E Kmonícková
Journal:  Br J Pharmacol       Date:  2009-04-03       Impact factor: 8.739

3.  Flavonols inhibit proinflammatory mediator release, intracellular calcium ion levels and protein kinase C theta phosphorylation in human mast cells.

Authors:  Duraisamy Kempuraj; Bhuvaneshwari Madhappan; Spyridon Christodoulou; William Boucher; Jing Cao; Nikoletta Papadopoulou; Curtis L Cetrulo; Theoharis C Theoharides
Journal:  Br J Pharmacol       Date:  2005-08       Impact factor: 8.739

4.  The hydroxyflavone, fisetin, suppresses mast cell activation induced by interaction with activated T cell membranes.

Authors:  K Nagai; Y Takahashi; I Mikami; T Fukusima; H Oike; M Kobori
Journal:  Br J Pharmacol       Date:  2009-08-20       Impact factor: 8.739

5.  Oral administration of SSC201, a medicinal herbal formula, suppresses atopic dermatitis-like skin lesions.

Authors:  Bo-Kyung Park; Yang-Chun Park; In Chul Jung; Seung-Hyung Kim; Jung-Eun Choi; Sunyoung Park; Jeong June Choi; Mirim Jin
Journal:  J Med Food       Date:  2014-01-29       Impact factor: 2.786

6.  The flavonoid luteolin inhibits niacin-induced flush.

Authors:  D Papaliodis; W Boucher; D Kempuraj; T C Theoharides
Journal:  Br J Pharmacol       Date:  2008-01-28       Impact factor: 8.739

7.  Flavonone treatment reverses airway inflammation and remodelling in an asthma murine model.

Authors:  A C Toledo; C P P Sakoda; A Perini; N M Pinheiro; R M Magalhães; S Grecco; I F L C Tibério; N O Câmara; M A Martins; J H G Lago; C M Prado
Journal:  Br J Pharmacol       Date:  2013-04       Impact factor: 8.739

Review 8.  New perspectives on natural flavonoids on COVID-19-induced lung injuries.

Authors:  Fernanda Paula R Santana; Fernanda Thevenard; Kaio S Gomes; Laura Taguchi; Niels Olsen S Câmara; Roberta S Stilhano; Rodrigo P Ureshino; Carla Maximo Prado; João Henrique Ghilardi Lago
Journal:  Phytother Res       Date:  2021-04-29       Impact factor: 6.388

9.  Flavonoid-mediated presenilin-1 phosphorylation reduces Alzheimer's disease beta-amyloid production.

Authors:  Kavon Rezai-Zadeh; R Douglas Shytle; Yun Bai; Jun Tian; Huayan Hou; Takashi Mori; Jin Zeng; Demian Obregon; Terrence Town; Jun Tan
Journal:  J Cell Mol Med       Date:  2008-04-09       Impact factor: 5.310

Review 10.  Inflammaging as a prodrome to Alzheimer's disease.

Authors:  Brian Giunta; Francisco Fernandez; William V Nikolic; Demian Obregon; Elona Rrapo; Terrence Town; Jun Tan
Journal:  J Neuroinflammation       Date:  2008-11-11       Impact factor: 8.322

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.